Search

everythinglearnresearchcommunity

for

Search:↓

A reliable method was created to measure dutasteride and related molecules in capsules.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

Finasteride and dutasteride effectively treat hair loss, with dutasteride showing slightly better results.

Low-dose dutasteride effectively and safely promotes hair growth in men.

Dutasteride 0.5 mg is safe and effective for long-term use in Korean men with hair loss.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Dutasteride is more effective than finasteride for hair loss treatment.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Using oral minoxidil and dutasteride together can quickly increase hair growth and volume with minimal side effects.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Rats had lasting erectile problems after stopping a certain medication.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.